Beacon Pointe Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Beacon Pointe Advisors, LLC

$8.89 Billion
Q1 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 14,610 shares of BMRN stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,610

Previous 17,838 18.1%

Holding current value

$1.2 Million

Previous $1.72 Million 25.77%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $270,538 - $319,572	-3,228 Reduced 18.1%	14,610 $1.28 Million
Q4 2023 Feb 08, 2024	SELL	$76.22 - $98.51 $10,137 - $13,101	-133 Reduced 0.74%	17,838 $1.72 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $30,284 - $33,634	-356 Reduced 1.94%	17,971 $1.59 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $63,189 - $73,118	-729 Reduced 3.83%	18,327 $1.59 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $120,379 - $160,894	1,372 Added 7.76%	19,056 $1.85 Million

Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $214,059 - $287,326	2,645 Added 17.59%	17,684 $1.83 Million
Q3 2022 Nov 09, 2022	SELL	$82.16 - $96.94 $20,786 - $24,525	-253 Reduced 1.65%	15,039 $1.27 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $80,415 - $97,706	-1,125 Reduced 6.85%	15,292 $1.27 Million
Q1 2022 May 17, 2022	BUY	$74.28 - $92.69 $111,345 - $138,942	1,499 Added 10.05%	16,417 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $126,514 - $161,353	-1,764 Reduced 10.57%	14,918 $1.32 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $692,370 - $791,452	9,260 Added 124.76%	16,682 $1.29 Million
Q2 2021 Aug 17, 2021	BUY	$75.51 - $84.79 $560,435 - $629,311	7,422 New	7,422 $619,000

Others Institutions Holding BMRN

# of Institutions

623

Shares Held

181M

Call Options Held

1.73M

Put Options Held

1.73M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Biomarin Pharmaceutical Inc Transaction History